|
🐜
|
Myocardial viability and survival in ischemic left ventricular dysfunction.
22 auth.
R. Bonow,
G. Maurer,
Kerry L Lee,
T. Holly,
P. Binkley,
P. Desvigne‐Nickens,
J. Drożdż,
P. Farsky,
A. Feldman,
T. Doenst,
...
R. Michler,
D. Berman,
J. Nicolau,
P. Pellikka,
Krzysztof Wróbel,
N. Alotti,
F. Asch,
L. Favaloro,
Lilin She,
E. Velazquez,
Robert H. Jones,
J. Panza
|
9 |
2011 |
9
🐜
|
|
🐜
|
Myocardial Viability and Long-Term Outcomes in Ischemic Cardiomyopathy.
20 auth.
J. Panza,
Alicia M. Ellis,
H. Al-Khalidi,
T. Holly,
D. Berman,
J. Oh,
G. Pohost,
G. Sopko,
L. Chrzanowski,
D. Mark,
...
T. Kukulski,
L. Favaloro,
G. Maurer,
P. Farsky,
R. Tan,
F. Asch,
E. Velazquez,
J. Rouleau,
Kerry L Lee,
R. Bonow
|
7 |
2019 |
7
🐜
|
|
🐜
|
Molecular identification of Trypanosoma cruzi discrete typing units in end-stage chronic Chagas heart disease and reactivation after heart transplantation.
15 auth.
J. Burgos,
M. Diez,
C. Vigliano,
M. Bisio,
M. Risso,
T. Duffy,
C. Cura,
Betina Brusses,
L. Favaloro,
M. Leguizamón,
...
R. H. Lucero,
R. Laguens,
M. Levin,
R. Favaloro,
A. Schijman
|
7 |
2010 |
7
🐜
|
|
🐜
|
Usefulness of PCR Strategies For Early Diagnosis of Chagas' Disease Reactivation and Treatment Follow‐Up in Heart Transplantation
11 auth.
M. Diez,
L. Favaloro,
A. Bertolotti,
J. Burgos,
C. Vigliano,
M. P. Lastra,
...
M. Levin,
A. Arnedo,
C. Nagel,
A. Schijman,
R. Favaloro
|
7 |
2007 |
7
🐜
|
|
🐜
|
Trypanosoma cruzi Discrete Typing Units in Chagas disease patients from endemic and non-endemic regions of Argentina
24 auth.
C. Cura,
R. H. Lucero,
M. Bisio,
E. Oshiro,
L. Formichelli,
J. Burgos,
S. Lejona,
B. Brusés,
D. Hernández,
G. Severini,
...
E. Velázquez,
T. Duffy,
E. Anchart,
R. Lattes,
J. Altcheh,
H. Freilij,
M. Diez,
C. Nagel,
C. Vigliano,
L. Favaloro,
R. Favaloro,
D. Merino,
S. Sosa-Estani,
A. Schijman
|
6 |
2012 |
6
🐜
|
|
🐜
|
Cardiomyocyte hypertrophy, oncosis, and autophagic vacuolization predict mortality in idiopathic dilated cardiomyopathy with advanced heart failure.
8 auth.
C. Vigliano,
P. C. Cabeza Meckert,
M. Diez,
L. Favaloro,
C. Cortés,
L. Fazzi,
...
R. Favaloro,
R. Laguens
|
5 |
2011 |
5
🐜
|
|
🦁
|
High‐dose plasmid‐mediated VEGF gene transfer is safe in patients with severe ischemic heart disease (Genesis‐I). A phase I, open‐label, two‐year follow‐up trial
11 auth.
L. Favaloro,
M. Diez,
O. Mendiz,
G. V. Janavel,
L. Valdivieso,
R. Ratto,
...
Guillermo Garelli,
F. Salmo,
M. Criscuolo,
A. Bercovich,
A. Crottogini
|
5 |
2013 |
5
🦁
|
|
🐜
|
Validation of the 2014 European Society of Cardiology Sudden Cardiac Death Risk Prediction Model in Hypertrophic Cardiomyopathy in a Reference Center in South America.
10 auth.
A. Fernández,
A. Quiroga,
J. P. Ochoa,
M. Mysuta,
J. Casabé,
M. Biagetti,
...
E. Guevara,
L. Favaloro,
A. Fava,
N. Galizio
|
5 |
2016 |
5
🐜
|
|
🐜
|
Comparison of prevalence, clinical course, and pathological findings of left ventricular systolic impairment versus normal systolic function in patients with hypertrophic cardiomyopathy.
8 auth.
A. Fernández,
C. Vigliano,
J. Casabé,
M. Diez,
L. Favaloro,
E. Guevara,
...
R. Favaloro,
R. Laguens
|
5 |
2011 |
5
🐜
|
|
🐜
|
Presence of Antigen-Experienced T Cells with Low Grade of Differentiation and Proliferative Potential in Chronic Chagas Disease Myocarditis
9 auth.
R. Argüello,
C. Vigliano,
Patricia Cabeza-Meckert,
R. Viotti,
F. Garelli,
L. Favaloro,
...
R. Favaloro,
R. Laguens,
S. Laucella
|
5 |
2014 |
5
🐜
|
